vanzacaftor

Indications

• in combination with tezacaftor & deutivacaftor for cystic fibrosis with at least one mutation in F508del or another responsive mutation in the CFTR gene

More general terms

• pulmonary agent

Component of

• eutivacaftor/tezacaftor/vanzacaftor (Alyftrek)

Database

• PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=139399801
• PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=139400306